- Mathias Wendt
- 08.10.24
- 1 min
- Energy consulting
Your contact person
Dr Helene Widowski
Anyone who has ever suffered a broken bone is aware of how time-consuming the healing process is and how much this can affect everyday life. Depending on the severity of the fracture, there are greater challenges to optimal recovery. Newer treatment approaches for complex fractures rely on regenerative bone medicine.
Unfortunately, there is still a lack of effective and long-term solutions for the treatment of large and complicated bone fractures. Particularly larger bone defects caused by trauma, tumor removal and infection, for example, exceed the bone's ability to regenerate itself and are dependent on major clinical interventions.
In order to revolutionize the treatment of bone fractures, new orthopaedic implants and therapy methods must be developed and implemented in medical practice.
The technological approach in regenerative bone medicine is not just to fill bone fractures with a conventional implant, which may have to be removed again during a second operation or replaced later with a new one, but to stimulate and support the bone's own healing power using innovative, biotechnologically produced implants made from biomaterials, tissue substitutes and bone growth factors.
The revolutionary treatment approach is that the bone regenerates itself in the long term and only the body's own bone material remains. As a result, innovative materials to promote bone healing will become increasingly important in regenerative medicine.
With the international innovation network “Reg4Bone – Innovative Technologies for Bone Regeneration”, EurA AG supports the initiation of R&D projects that can revolutionize the treatment approach to overcome the constant challenge of complex bone fractures. The network is funded by the ZIM (Central Innovation Program for SMEs). Innovative solutions are generated, investigated and produced within the network together with scientific institutions, small and medium-sized companies, clinics and medical practices.
If you are also active in the field of innovative bioresorbable implant materials, tissue engineering or sensory technologies and would like to be involved in the future progress of innovative bone regeneration treatments, please contact us. The EurA team of experts in the field of life science is there for you. Further information on the ZIM-funded international network Reg4Bone can be found here.
Text: Dr Helene Widowski
Your contact person
Dr Helene Widowski
EurA AG
T- 079619256-0Max-Eyth-Straße 2
73479 Ellwangen
info@eura-ag.com